|
| 回到 StockQ 正常版首頁 |
|
| 技術線圖 |
| 5日平均 | 10日平均 | 20日平均 |
| 2457.92 | 2400.31 | 2369.74 |
| 60日平均 | 120日平均 | 260日平均 |
| 2187.75 | 2125.14 | 2058.41 |
| Date | Price | Change% |
| 2025/08/15 | 2534.2188 | 2.61% |
| 2025/08/14 | 2469.6555 | -1.08% |
| 2025/08/13 | 2496.5042 | 3.62% |
| 2025/08/12 | 2409.3982 | 1.24% |
| 2025/08/11 | 2379.816 | 1.96% |
| 2025/08/08 | 2333.959 | -0.38% |
| 2025/08/07 | 2342.8608 | -0.68% |
| 2025/08/06 | 2358.9546 | 0.66% |
| 2025/08/05 | 2343.376 | 0.39% |
| 2025/08/04 | 2334.323 | 0.50% |
| 2025/08/01 | 2322.627 | -0.24% |
| 2025/07/31 | 2328.313 | -1.66% |
| 2025/07/30 | 2367.6836 | -1.62% |
| 2025/07/29 | 2406.5945 | 1.86% |
| 2025/07/28 | 2362.5996 | 0.96% |
| 2025/07/25 | 2340.0557 | -0.23% |
| 2025/07/24 | 2345.367 | 1.50% |
| 2025/07/23 | 2310.671 | -0.01% |
| 2025/07/22 | 2310.856 | 0.61% |
| 2025/07/21 | 2296.883 | 0.87% |
相關基金績效 (可點按欄位名稱排序)
| 名稱 | 三個月 | 六個月 | 一年 | 今年 |
| 創業板指指數 | 25.47% | 19.88% | 42.61% | 17.22% |
| 聯博中國優化波動股票基金-A股/美元 | 4.47% | -3.17% | -12.52% | 2.34% |
| 聯博中國優化波動股票基金-A股/歐元 | 2.85% | -5.25% | -15.61% | 3.30% |
| 聯博中國A股基金-A2類型/台幣 | 10.05% | 2.14% | 17.91% | 3.99% |
| 聯博中國A股基金-A2類型/美元 | 11.15% | 11.59% | 26.95% | 13.64% |
| 聯博中國A股基金-A2類型/人民幣 | 10.72% | 10.19% | 27.63% | 11.09% |
| 富達中國聚焦基金/美元 | 8.79% | 12.76% | 32.60% | 20.10% |
| 法巴中國股票基金-C股/美元 | 18.77% | 22.80% | 31.79% | 18.92% |
| 安聯中國策略基金/台幣 | 7.78% | -0.53% | 17.76% | 2.07% |
| 安聯中國股票基金-A股/配息/美元 | 11.44% | 13.96% | 41.08% | 27.26% |
| 霸菱香港中國基金-A類/配息/歐元 | 2.71% | -3.92% | 25.74% | 7.82% |
| 霸菱香港中國基金-A類/配息/美元 | 6.94% | 7.34% | 33.41% | 21.11% |
| 霸菱香港中國基金-A類/配息/英鎊 | 5.13% | -0.56% | 26.18% | 11.85% |
| 貝萊德中國基金A2/美元 | 6.49% | 6.03% | 34.16% | 20.23% |
| 貝萊德中國基金A2-歐元避險 | 5.74% | 4.52% | 30.47% | 17.89% |
| 貝萊德中國基金A2-澳幣避險 | 6.23% | 4.55% | 30.66% | 18.09% |
| 群益華夏盛世基金/台幣 | 6.90% | -1.90% | 4.45% | -1.40% |
| 群益華夏盛世基金/美元 | 7.94% | 7.14% | 12.47% | 7.74% |
| 群益華夏盛世基金/人民幣 | 7.48% | 5.71% | 12.92% | 5.60% |
| 群益中國新機會基金/台幣 | 7.88% | -1.79% | 5.63% | -0.45% |
| 群益中國新機會基金/美元 | 8.99% | 7.40% | 13.83% | 8.84% |
| 群益中國新機會基金/人民幣 | 8.52% | 5.96% | 14.29% | 6.69% |
| DWS投資中國股票基金E2/美元 | 3.65% | 17.91% | 23.93% | 15.77% |
| DWS投資中國股票基金A2/美元 | 14.96% | 19.61% | 24.27% | 15.09% |
| DWS投資中國股票基金FC/歐元 | -2.39% | 3.13% | 13.75% | 2.31% |
| DWS投資中國股票基金LC/歐元 | 8.52% | 5.45% | 15.14% | 2.42% |
| 瀚亞中國基金/台幣 | 15.37% | 6.23% | 21.61% | 9.34% |
| 瀚亞中國股票基金/美元 | 10.31% | 13.52% | 42.35% | 27.50% |
| 愛德蒙得洛希爾中國基金(A)/歐元 | -1.76% | 3.10% | 23.33% | 2.06% |
| 愛德蒙得洛希爾中國基金(A)/美元 | 3.84% | 17.76% | 34.15% | 15.82% |
| 歐義銳榮中國股票基金-R/歐元 | 5.16% | 2.99% | 33.48% | 10.72% |
| 歐義銳榮中國股票基金-R2/美元 | 10.41% | 15.68% | 42.78% | 25.30% |
| 首域盈信中國核心基金/美元 | 9.16% | 12.40% | 18.57% | 6.94% |
| 富蘭克林華美中國消費基金/台幣 | 6.31% | -2.10% | 6.43% | -0.81% |
| 富蘭克林華美中國傘型基金之中國A股基金/台幣 | 6.61% | -4.07% | 3.57% | -3.22% |
| 富蘭克林華美中國傘型基金之中國A股基金/人民幣 | 7.18% | 3.72% | 12.21% | 3.59% |
| 富蘭克林華美中國傘型基金之中國A股基金/美元 | 7.64% | 4.81% | 11.57% | 5.77% |
| 復華華人世紀基金/台幣 | 31.23% | 20.54% | 52.48% | 29.81% |
| 復華大中華中小策略基金/台幣 | 12.29% | -2.50% | 6.84% | -4.45% |
| 匯豐中國動力基金-台幣 | 13.26% | 5.58% | 21.60% | 8.46% |
| 匯豐中國股票基金AD/美元 | 13.70% | 18.83% | 17.02% | 13.93% |
| 景順中國基金-A股/美元 | 7.94% | 7.57% | 36.88% | 20.92% |
| 景順中國基金-A股/歐元對沖 | 7.13% | 6.81% | 33.50% | 19.44% |
| 景順中國基金-A股/澳幣對沖 | 7.66% | 6.85% | 33.96% | 19.81% |
| 摩根中國基金-A股/分派/美元 | 7.44% | 7.61% | 38.30% | 20.15% |
| 木星中國基金-ACC/美元 | -7.75% | -3.82% | -6.93% | -12.97% |
| 木星中國基金–ACC/英鎊 | 13.43% | 16.64% | 37.41% | 13.75% |
| 野村中國機會基金/台幣 | 11.67% | 2.95% | 20.16% | 8.81% |
| 鋒裕匯理-中國股票基金-A2/美元 | 4.07% | 17.28% | 24.44% | 15.57% |
| 鋒裕匯理-中國股票基金-B2/美元 | 3.90% | 16.86% | 23.56% | 15.21% |
| 鋒裕匯理-中國股票基金-A2/歐元 | -1.77% | 2.48% | 14.18% | 1.67% |
| 荷寶中國股票基金-D/歐元 | -10.74% | -12.16% | -24.25% | -23.76% |
| 荷寶中國股票基金-D/美元 | -5.71% | -10.92% | -21.01% | -20.63% |
| 新光中國成長基金/台幣 | 8.43% | -3.15% | 17.66% | 2.98% |
| 瑞銀(盧森堡)中國精選股票基金/美元 | 12.28% | 17.75% | 40.83% | 28.52% |
| 瑞銀(盧森堡)中國精選股票基金-月配息/美元 | 11.73% | 16.61% | 38.03% | 27.05% |
| 元大新中國基金/台幣 | 0.68% | -7.70% | 3.20% | -4.09% |
| ( 中國基金 ) | 7.37% | 6.24% | 20.48% | 9.74% |
| ||||||||||||
|
StockQ 全球股市指數 © All rights reserved.
|